AB127. Unequal Access, unequal outcomes: disparities in availability and accessibility to self-injectable adrenaline for pediatric anaphylaxis in Asia-Pacific

  • Yau, Phoebe C.Y.; 
  • Mak, Hugo W.F.; 
  • Tham, Elizabeth Huiwen; 
  • Pacharn, Punchama; 
  • Xing, Yuhan; 
  • ... Ahn, Kangmo; 
  • 외 8명
Citations

SCOPUS

0

초록

Background: Pediatric anaphylaxis is under-investigated in Asia-Pacific, with its management remains under-reported. This study aims to report and compare the management practice of pediatric anaphylaxis among Asia-Pacific localities. Methods: Data from the Asia-Pacific Research Network for Anaphylaxis, a prospective regional pediatric anaphylaxis registry with 16 participating centers from Hong Kong, Singapore, Thailand, and Qingdao, were analyzed. The management strategies across regions were compared. The outcomes of patients with and without self-injectable adrenaline before anaphylaxis were also contrasted. Results: A total of 721 anaphylaxis episodes in 689 patients, spanning from 2019 to 2022, were included. Overall, while adrenaline was administered in 434 (60.2%) episodes, only 64 (8.9%) were given pre-hospital adrenaline. Almost all patients in Thailand (95.8%, 113/118) and Singapore (93.3%, 237/254) received adrenaline, whose usage was significantly lower in Hong Kong (30.1%, 66/219) and Qingdao (13.8%, 18/130; P<0.001). Only 89 (12.3%) children owned an adrenaline device before an episode of anaphylaxis, with significantly different rates of ownership among regions (P<0.001): 18.9% (48/254) children in Singapore possessed a device, followed by 15.3% (18/118) in Thailand, 10.5% (23/219) in Hong Kong, and none in Qingdao. Compared to individuals without an adrenaline device before an anaphylactic event, those who owned one had significantly higher overall (80.9% vs. 57.3%, P<0.001) and pre-hospital use of adrenaline (49.4% vs. 3.2%, P<0.001) shorter time to first-dose administration (mean: 73.4±98.2 vs. 159.8±476.5 minutes, P<0.001), lower proportion of severe anaphylaxis (World Allergy Organization grade 4–5 reactions; 9.0% vs. 18.4%, P=0.03), and reduced length of admission (mean: 1.0±0.7 vs. 2.3±7.5 days, P<0.001). Conclusions: Disparities in anaphylaxis management persist in Asia-Pacific, likely due to limited adrenaline autoinjector access in developing countries, as well as underuse in developed regions. Patients who owned an adrenaline device demonstrated significantly better outcomes than those who did not. © AME Publishing Company.

키워드

adrenaline autoinjector; Asia-Pacific disparities; Pediatric anaphylaxis
제목
AB127. Unequal Access, unequal outcomes: disparities in availability and accessibility to self-injectable adrenaline for pediatric anaphylaxis in Asia-Pacific
저자
Yau, Phoebe C.Y.; Mak, Hugo W.F.; Tham, Elizabeth Huiwen; Pacharn, Punchama; Xing, Yuhan; Trinh, Hoang Kim Tu; Lee, Sooyoung; Ahn, Kangmo; Chatchatee, Pantipa; Sato, Sakura; Ebisawa, Motohiro; Lee, Bee Wah; Wong, Gary Wing Kin; Leung, Agnes Sze Yin
DOI
10.21037/jphe-26-ab127
발행일
2026
유형
Article
저널명
Journal of Public Health and Emergency
권
10